
CLAZAKIZUMAB (ANTI-IL-6 MONOCLONAL) TREATMENT OF PATIENTS WITH CHRONIC & ACTIVE ANTIBODY-MEDIATED REJECTION POST-KIDNEY TRANSPLANTATION (NCT03380377)
Author(s) -
Stanley C. Jordan,
Noriko Ammerman,
Mieko Toyoda,
Shili Ge,
Edmund Huang,
Alice Peng,
Supreet Sethi,
Reiad Najjar,
Edwin Ortiz,
Maggie Chu,
Abner De Guzman,
Irene Kim,
Kathlyn Lim,
Jua Choi,
Ashley Vo
Publication year - 2020
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000698592.29821.e5
Subject(s) - medicine , transplantation , biopsy , surgery , dosing , urology , monoclonal antibody , kidney transplantation , gastroenterology , antibody , immunology